Cargando…

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

BACKGROUND: Observational studies have suggested increased arrhythmic and cardiovascular risk with the combination use of hydroxychloroquine (HCQ) and azithromycin in patients with coronavirus disease 2019 (COVID-19). OBJECTIVE: The arrhythmic safety profile of HCQ monotherapy, which remains under i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sridhar, Arun R., Chatterjee, Neal A., Saour, Basil, Nguyen, Dan, Starnes, Elizabeth A., Johnston, Christine, Green, Margaret L., Roth, Gregory A., Poole, Jeanne E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289101/ https://www.ncbi.nlm.nih.gov/pubmed/32835316 http://dx.doi.org/10.1016/j.hroo.2020.06.002

Ejemplares similares

Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin
por: Cipriani, Alberto, et al.
Publicado: (2020)

Effects of hydroxychloroquine treatment on QT interval
por: Hooks, Matthew, et al.
Publicado: (2020)

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

Quantifying arrhythmic long QT effects of hydroxychloroquine and azithromycin with whole-heart optical mapping and simulations
por: Uzelac, Ilija, et al.
Publicado: (2021)

Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients
por: Russo, Vincenzo, et al.
Publicado: (2020)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

COVID-19 treatments, QT interval, and arrhythmic risk: The need for an international registry on arrhythmias
por: Crotti, Lia, et al.
Publicado: (2020)

Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring
por: Ramireddy, Archana, et al.
Publicado: (2020)

Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin
por: Anupama, B K, et al.
Publicado: (2020)

System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation
por: Khan, Abdul Arif, et al.
Publicado: (2020)

Hydroxychloroquine: Prolonged QT interval following off label use: case report
Publicado: (2020)

Prolongation of QT interval due to hydroxychloroquine overdose used in COVID-19 treatment
por: Aksel, Gökhan, et al.
Publicado: (2020)

Hydroxychloroquine: QT interval prolongation following off-label use: case report
Publicado: (2022)

THE EFFECT OF TREATMENT WITH HYDROXYCHLOROQUINE AND AZITHROMYCIN ON THE CORRECTED QT INTERVAL IN PATIENTS WITH COVID-19
por: Batemarco, Thomas, et al.
Publicado: (2022)

Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen
por: Bernardini, Andrea, et al.
Publicado: (2021)

Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19
por: Echarte-Morales, Julio, et al.
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolonged QT interval during off label use: case report
Publicado: (2021)

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
por: Chorin, Ehud, et al.
Publicado: (2020)

Echocardiography-Guided Arrhythmic Risk Prediction in the Long QT Syndrome
por: Agarwal, Rakesh, et al.
Publicado: (2021)

Azithromycin/hydroxychloroquine interaction: QT interval prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Corrected QT-interval prolongation following off label use: case report
Publicado: (2020)

Hydroxychloroquine/remdesivir/tocilizumab: Increase in corrected QT interval and off-label use: case report
Publicado: (2020)

Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection
por: Voisin, Olivier, et al.
Publicado: (2020)

Hydroxychloroquine: Electrical storm and QT interval prolongation following off-label use: case report
Publicado: (2020)

HYDROXYCHLOROQUINE ATTENUATES HERG CHANNEL BY PROMOTING THE MEMBRANE CHANNEL DEGRADATION: EVIDENCES FOR QT-INTERVAL PROLONGATION IN COVID-19 PATIENTS WITH HYDROXYCHLOROQUINE TREATMENT
por: Wang, Xiqiang, et al.
Publicado: (2022)

The Measurement of the QT Interval
por: Postema, Pieter G, et al.
Publicado: (2014)

Effects of Short-Term Hydroxychloroquine Plus Moxifloxacin Therapy on Corrected QT Interval and Tp-e Interval in Patients With COVID-19
por: Afsin, Abdulmecit, et al.
Publicado: (2020)

Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death
por: Walsh, Roddy, et al.
Publicado: (2021)

Arrhythmic risk during pregnancy and postpartum in patients with long QT syndrome
por: Asatryan, Babken, et al.
Publicado: (2021)

QT interval evaluation associated with the use of hydroxychloroquine with combined use of azithromycin among hospitalised children positive for coronavirus disease 2019
por: Tuncer, Tunc, et al.
Publicado: (2020)

QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy
por: Sala, Michela, et al.
Publicado: (2005)

Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients
por: Eftekhar, Seyed Parsa, et al.
Publicado: (2021)

Tp-e interval, Tp-e/QT, and Tp-e/QTc ratios in patients with primary hyperparathyroidism and their relationship with cardiac arrhythmic events
por: YILMAZ, Yücel, et al.
Publicado: (2021)

Measuring the QT interval on the go
por: McIntyre, William F., et al.
Publicado: (2021)

Pro-arrhythmic effects of gain-of-function potassium channel mutations in the short QT syndrome
por: Hancox, J. C., et al.
Publicado: (2023)

TCT CONNECT-217 Hydroxychloroquine and Azithromycin Usage in African American Patients With Coronavirus Disease 2019 (COVID-19) and Their Effects on QT Interval
por: Al-Sadawi, Mohammed, et al.
Publicado: (2020)

The QT Interval in Research
por: Somberg, John
Publicado: (2021)

An antiarrhythmic approach to hydroxychloroquine-induced QT prolongation
por: Yetkin, E., et al.
Publicado: (2020)

Hydroxychloroquine: risk of QT prolongation and drug interactions
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nrokvsifuc06u91u4g0geljp8t